RE:RE:RE:RE:RE:RE:Waiting to discuss P1 on Oct 13 will not be a good signIf you are asking for full phase 1b data before 10/13, you don't understand how this works. What exactly are you asking TH to release before 10/13? They could announce proof of concept. They could announce a protocol extension filing. They could tell us how many patients they have had in the trial. They could tell us anything they wanted to since it is an open label trial but that is not how things are typically done. So, what is it you want them to tell us?
Joemare wrote: They've had plenty of time to recruit, add sites, visit them, lead the sites, push the sites to recruit etc.
That's what a CEO and VP have to do. Not providing any P1 data between now and the 13th is a failure. If they have P1 data, it's material. They need to tell shareholders.
If they wait for the 13th, then whatever they will say will not in any way sustain an increase in shareprice. It will be bla bla bla promises and excuses.